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 Summary
 Background: To assess multimodal imaging features of medication-related osteonecrosis of the jaw (MRONJ) and 
to analyze the differences between oral and parenteral routes of medication administration. We 
retrospectively reviewed panoramic radiographs, CT, MRI, and bone scintigraphy of patients with 
MRONJ.
 Material/Methods: A retrospective study was conducted in 16 patients with MRONJ who underwent panoramic 
radiography, CT, MRI, and bone scintigraphy. Statistical analysis for the comparison between routes 
of medication administration and multimodal imaging features was performed with the Pearson’s 
c2 test.
 Results: The percentage of cases with sequestrum separation was 25.0% (4/16 cases) on panoramic 
radiography and 81.3% (13/16 cases) on CT. The percentage of cases with periosteal bone 
proliferation on CT was 41.7% (5/12 cases) in the oral route of administration vs. 100% (4/4 cases) in 
the parenteral route of administration (p=0.042). The percentage of cases with spread of soft tissue 
inflammation to buccal and other spaces on CT and MRI was 33.3% (4/12 cases) in the oral route of 
administration vs. 100% (4/4 cases) in the parenteral route of administration (p=0.021).
 Conclusions: The sequestrum separation on panoramic radiography in patients with MRONJ was unclear in 
comparison to CT. Furthermore, characteristic CT findings of patients with MRONJ in the 
parenteral administration group were periosteal bone proliferation and spread of soft tissue 
inflammation to buccal and other spaces.
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Bisphosphonates are inhibitors of osteoclastic bone resorp-
tion. They are effective in treating osteoporosis and other 
metabolic bone diseases, and prevent skeletal events asso-
ciated with metastatic neoplasms [1–5]. Although bispho-
sphonates are effective, they are also implicated in the 
development of medication-related osteonecrosis of the jaw 
(MRONJ) [6,7].
In recent years, many authors have reported that long-
term use of bisphosphonates and other anti-resorptive 
medications, especially long-term high-dose intravenous 
bisphosphonates, may cause osteonecrosis of the jaws 
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(MRONJ) [8]. Such patients are often referred to radiologi-
cal institutes for the evaluation of bisphosphonate-induced 
changes in the jaws, and in order to exclude other diseas-
es of the jaws, e.g., infected osteoradionecrosis or chronic 
osteomyelitis. Such an evaluation of the jaws is necessary 
before all orofacial procedure can be performed [9].
Panoramic radiography is one of the imaging modalities that 
is used most commonly by dentists and oral and maxillofa-
cial surgeons because of their familiarity with this modal-
ity. Computed tomography (CT), magnetic resonance imaging 
(MRI), and scintigraphy offer a greater advantage compared 
with panoramic radiography as regards the evaluation of the 
jaws. Imaging of the jaws is important in the diagnosis and 
management of MRONJ. The aim of this study was to assess 
multimodal imaging features of medication-related osteone-
crosis of the jaw (MRONJ) and to compare between oral and 
parenteral routes of medication administration, with the use 
of panoramic radiography, CT, MRI, and bone scintigraphy.
Material and Methods
Patients
This retrospective study was approved by the ethics com-
mittee of our institution. After providing written informed 
consent, 16 patients (0 male, 16 female; age 48–89 years, 
mean age 76.2 years) with MRONJ underwent panoramic 
radiography, CT, MRI, and bone scintigraphy in our uni-
versity hospital from January 2012 to September 2016. 
The diagnosis of MRONJ was made according to the 
position papers of the American Association of Oral and 
Maxillofacial Surgery [10], as follows: (1) current or previ-
ous treatment with a bisphosphonate; (2) exposed bone or 
bone that can be probed through an intraoral or extraoral 
fistula in the maxillofacial region that has persisted for 
longer than 8 weeks; and (3) no history of radiation ther-
apy to the jaws or obvious metastatic disease to the jaws. 
Furthermore, the histopathological diagnoses of MRONJ 
Number of patients
Administration of medication
Oral (12) Inject (4) Total (16)
Age (years)
 Mean ±SD 81.3±5.4 61.0±10.6 76.2±11.2
 Range 74–89 48–73 48–89
Sex
 Male 0 0 0
 Female 12 4 16
Primary disease
 Osteoporosis 11 0 11
 Rheumatism 1 0 1
 Osseous metastases of breast cancer 0 4 4
Medication
 Alendronate 5 0 5
 Risedronate 5 0 5
 Minodronate 2 0 2
 Zoledronate 0 3 3
 Denosumab 0 1 1
Location of MRONJ
 Mandible 11 4 15
 Maxilla 1 0 1
Staging of MRONJ
 Stage 1 0 0 0
 Stage 2 0 0 0
 Stage 3 10 3 13
 Stage 4 2 1 3
Table 1. Characteristics of the patients with MRONJ.
MRONJ – medication-related osteonecrosis of the jaw; SD – standard deviation.
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were confirmed by surgery in all cases. Table 1 shows char-
acteristics of the patients with MRONJ.
Image acquisition
Panoramic radiographs were performed with a panoramic 
machine (Veraviewepocs; J MORITA MFG, Kyoto, Japan) 
using the maxillofacial protocol of our hospital, as follows: 
tube voltage, 70 kV; tube current, 10 mA.
CT imaging was performed with a 16-multidetector CT 
scanner (Aquilion TSX-101A; Toshiba Medical Systems, 
Otawara, Japan) using the maxillofacial protocol of our 
hospital, as follows: tube voltage, 120 kV; tube current, 
300 mA; field of view, 240×240 mm; and rotation time, 
0.5 s. The protocol consisted of axial acquisition (0.50 mm) 
with axial, coronal, and sagittal multiplanar reformation 
(MPR) images. The patients underwent contrast-enhanced 
CT (CECT) with nonionic iodine to assess head and neck 
lesions. One nonionic contrast agent was used, Iohexol 
300 mgI/mL (Omunipaque 300 Syringe, Daiichi-Sankyo, 
Tokyo, Japan). The contrast agent was administered as 
an injection (100 mL), at a rate of 2.0 mL/s (Autoenhance 
A-250, Nemoto-Kyorindo, Tokyo, Japan).
The MR images (head coil, 1.5 Tesla MR unit; EXCELART 
Vantage MRT-2003; Toshiba Medical Systems, Otawara, 
Japan) included unenhanced axial T1 sequences [repeti-
tion time (TR) 660 ms, echo time (TE) 12 ms], T2-weightted 
sequences (TR 4000 ms, TE 120 ms), short TI inversion 
recovery sequences (TR 2500 ms, TE 15 ms, TI 190 ms), 
and coronal T1-weighted sequences. After injecting con-
trast medium (gadobutrol; Gadovist 1.0mol/L Syringe, 
Bayer, Osaka, Japan; 0.1 mL/kg), axial and coronal 
T1-weighted images (TR 660 ms, TE 12 ms) were acquired.
Four hours after injection, bone scintigraphy was per-
formed with an SNC-5100R (Shimadzu, Kyoto, Japan) and 
a Scintipack 24000 (Shimadzu) with a 128×128 matrix. The 
images were recorded on a computer at 5 min/frame. The 
radiopharmaceutical used in this study was 99mTc-labeled 
hydroxymethylene diphosphonate (99mTc HMDP) (Nihon 
Medi-Physics, Tokyo, Japan). Each patient was adminis-





Panoramic radiography 12 patients 4 patients 16 patients
 Osteolytic changes of the jaws  12 (100%)  4 (100%)  16 (100%)
 Sclerotic lesions  12 (100%)  4 (100%)  16 (100%)
 Sequestrum separation  4 (33.3%)  0 (0%)  4 (25.0%) 0.182
CT images 12 patients 4 patients 16 patients
 Osteolytic changes of the jaws  12 (100%)  4 (100%)  16 (100%)
 Sclerotic lesions  12 (100%)  4 (100%)  16 (100%)
 Sequestrum separation  11 (91.7%)  2 (50.0%)  13 (81.3%) 0.064
 Periosteal bone proliferation  5 (41.7%)  4 (100%)  9 (56.3%) 0.042*
 External dental fistula  2 (16.7%)  1 (25.0%)  3 (18.8%) 0.712
 Spread of soft tissue inflammation
  Buccal space  8 (66.7%)  0 (0%)  8 (50.0%)
  Buccal and other spaces  4 (33.3%)  4 (100%)  8 (50.0%) 0.021*
MR images 12 patients 4 patients 16 patients
 Special attention to intensity changes  12 (100%)  4 (100%)  16 (100%)
 Pathological gadolinium enhancement  12 (100%)  4 (100%)  16 (100%)
 Spread of soft tissue inflammation
  Buccal space  8 (66.7%)  0 (0%)  8 (50.0%)
  Buccal and other spaces  4 (33.3%)  4 (100%)  8 (50.0%) 0.021*
Bone scintigraphy 4 patients 1 patient 5 patients
 Increased uptake  4 (100%)  1 (100%)  5 (100%)
Table 2. Multimodality imaging features of MRONJ with panoramic radiography, CT, MRI and bone scintigraphy.
* Significant difference (p<0.05).













Figure 1.  Multimodal imaging in a 79-year-old woman with osteoporosis who received oral alendronate. The patient presented with left 
mandibular pain. Panoramic radiography (A) shows osteolytic changes in the jaws and sclerotic lesions, however, sequestrum separation 
was unclear (arrow). Axial contrast-enhanced CT image (B) shows spread of soft tissue inflammation to buccal space (arrowheads). Axial 
(C) and coronal (D) bone tissue algorithm CT shows osteolytic changes in the jaws, sclerotic lesions, sequestrum separation (arrow), and 
periosteal bone proliferation (arrowheads). Bone scintigraphy (E) shows increased uptake (arrow). On MRI, axial T1-weighted image 
(T1WI) (F) revealed homogeneous, low-signal intensity with no hyperintensity, suggestive of sequestrum (arrow). Post-contrast T1WI (I) 
showed heterogeneous enhancement and a non-enhancing portion, suggestive of sequestrum (arrow). T2-weighted image (T2WI) (G) 
and short TI inversion recovery (STIR) (H) revealed heterogeneous, high-signal intensity with no hyperintensity and spread of soft tissue 
inflammation to buccal space (arrow).
with a rapid intravenous injection. The stored data were 
displayed on a screen for analysis.
Image analysis
Two oral and maxillofacial radiologists, with over 20 years 
of experience, independently reviewed all images, and 
any discrepancies were resolved by consensus. The pano-
ramic radiographs were reviewed with regard to osteolyt-
ic changes of the jaws, sclerotic lesions, and sequestrum 
separation. The acquired CT images were reviewed with 
regard to osteolytic changes of the jaws, sclerotic lesions, 
sequestrum separation, periosteal bone proliferation, 
external dental fistula, and spread of soft tissue inflamma-
tion (buccal, submandibular, sublingual, masticator, and 
parapharyngeal space). The MR images of the jaws were 
assessed with special attention to intensity changes of the 
cortical and subcortical bony structures, pathological gado-
linium enhancement, and spread of soft tissue inflamma-
tion (buccal, submandibular, sublingual, masticator, and 
parapharyngeal space). Bone scintigraphy of the jaws was 
assessed with increased uptake.
Statistical analysis
Statistical analysis for the comparison between routes of 
administration and multimodal imaging features of pano-
ramic radiography, CT, MRI, and bone scintigraphy was 
performed with the Pearson’s c2 test. These analyses were 
performed with the IBM SPSS Statistics statistical package, 







version 24 (IBM Japan, Tokyo, Japan). A P lower than 0.05 
was considered as statistically significant.
Results
Table 2 shows multimodal imaging features of MRONJ 
that were seen on panoramic radiography, CT, MRI, and 
bone scintigraphy. All cases showed osteolytic changes in 
the jaws and sclerotic lesions on panoramic radiography 
and CT. The percentage of cases with sequestrum separa-
tion was 25.0% (4/16 cases) on panoramic radiography and 
81.3% (13/16 cases) on CT.
Regarding the comparison between oral and parenteral 
routes of administering medication, the percentage of cases 
with periosteal bone proliferation on CT was 41.7% (5/12 
cases) in the case of oral administration vs. 100% (4/4 cases) 







Figure 2.  Multimodal imaging in an 89-year-old woman with osteoporosis who received oral alendronate. The patient presented with left 
mandibular pain. Panoramic radiography (A) shows osteolytic changes in the jaws, sclerotic lesions, and sequestrum separation 
(arrow). Axial contrast-enhanced CT image (B) shows spread of soft tissue inflammation to buccal, sublingual, and masticator spaces 
(arrowheads). Axial (C) and coronal (D) bone tissue algorithm CT shows osteolytic changes in the jaws, sclerotic lesions, sequestrum 
separation (arrow). Bone scintigraphy (E) shows increased uptake (arrow). On MRI, axial T1WI (F) revealed homogeneous, low-signal 
intensity with no hyperintensity, suggestive of sequestrum (arrow). Post-contrast T1WI (I) showed heterogeneous enhancement and a 
non-enhancing portion, suggestive of sequestrum (arrow). T2WI (G) and STIR (H) revealed heterogeneous, high-signal intensity with no 
hyperintensity and spread of soft tissue inflammation to buccal, sublingual, and masticator spaces (arrow).
cases had intensity changes and pathological gadolinium 
enhancement on MRI. The percentage of cases with spread 
of soft tissue inflammation to buccal and other spaces 
on CT and MRI was 33.3% (4/12 cases) in the case of oral 
administration vs. 100% (4/4 cases) in the case of paren-
teral administration (p=0.021). All cases showed increased 
uptake on bone scintigraphy.
Figures 1–3 show multimodal imaging in 3 cases with 
MRONJ on panoramic radiography, CT, MRI, and bone 
scintigraphy.
Discussion
Bisphosphonates are frequently used for the treatment 
of osseous metastases and osteoporosis. The incidence of 
bisphosphonate-related osteonecrosis of the jaw (BRONJ) 
or MRONJ is dependent on a number of factors includ-
ing the type of bisphosphonate used (zoledronic acid and 
pamidronate disodium carry the highest risk), the route 
of administration (the intravenous route carries a higher 
risk), the dose, and possibly the duration of therapy [1]. 
However, detailed studies comparing the imaging charac-
teristics of MRONJ have not yet been performed [6]. The 
authors assessed multimodal imaging features of MRONJ 
with panoramic radiography, CT, MRI, and bone scintig-
raphy, especially as regards the comparison between oral 
and parenteral routes of administering medications. This 
study indicated that the sequestrum separation on pano-
ramic radiography in patients with MRONJ was unclear in 
comparison to CT. Furthermore, characteristic CT and MRI 
findings of patients with MRONJ in the parenteral group 
included periosteal bone proliferation and spread of soft 
tissue inflammation to buccal and other spaces.
Conventional anatomic imaging, including periapical radio-
graphs and panoramic x-rays, allow for quick visualization 
of the areas of concern, but one must keep in mind the lag 




between bone changes and the appearance of radiograph-
ic findings, which could be up to 2 weeks [2]. Ruggiero [7] 
showed that the radiographic features of MRONJ remain 
relatively nonspecific. Regarding panoramic radiography of 
MRONJ, Klingelhöffer et al. [11] indicated that panoramic 
radiographs of patients undergoing antiresorptive therapy 
with manifested osteonecrosis more frequently showed 
changes in the bone structure. Ozcan et al. [12] suggested 
that the osseous changes associated with BRONJ in the 
mandible, which includes the cortical and spongious bones, 
do not reflect the external morphology of the mandible on 
panoramic images. Torres et al. [13] suggested that man-
dibular inferior cortical bone thickness in patients using 
bisphosphonates was detected on panoramic radiographs, 
and represented a potentially useful tool for the detection 
of dimensional changes associated with bisphosphonate 
therapy. In this study, we demonstrate that the sequestrum 
separation that can be seen on panoramic radiography in 
patients with MRONJ is unclear in comparison to CT.
CT helps to identify findings difficult to discern on plain 
radiographs and also provides three-dimensional informa-
tion and better delineation of the extent of the lesions [2]. 
Regarding CT of MRONJ, Bisdas et al. [9] showed that CT 
images showed predominantly osteolytic lesions and scle-
rotic regions in the jaws with or without periosteal bone 
proliferation. Krishnan et al. [1] showed that, on CT, sclero-
sis, subtle lucencies of the periodontal ligament, cortex and 
around the apices of the teeth (in the early stage), osteo-
lytic bone lesions, cortical disruption, and frank bone frag-
mentation (in the later stages) were observed. Guo et al. 
[8] showed that both panoramic radiography and CT could 
detect the typical syndrome of osseous sclerosis in MRONJ, 
Stage 0 and 1, and in patients with BRONJ, Stage 2. More 
features were observed on CT, such as periosteal reac-
tion, cortical perforation, and periosteal bone deposition. 
Imai et al. [14] showed that the measurement of CT values 
may be useful for diagnosis and early detection of BRONJ. 
Ruggiero [7] showed that the CT findings of MRONJ are 
nonspecific, but this modality is significantly more sen-
sitive to changes in bone mineralization and therefore is 
more likely to demonstrate areas of focal sclerosis, thick-
ened lamina dura, early sequestrum formation, and the 
presence of reactive periosteal bone. In this study, we 
noted that characteristic CT findings of MRONJ in patients 
in the parenteral groups included periosteal bone prolifera-




Figure 3.  Multimodal imaging in a 58-year-old woman with osseous metastases of breast cancer who received parenteral zoledronate. The patient 
presented with left mandibular pain. Panoramic radiography (A) shows osteolytic changes in the jaws and sclerotic lesions, however, 
sequestrum separation was unclear (arrow). Axial contrast-enhanced CT image (B) shows spread of soft tissue inflammation to buccal, 
submandibular, and masticator spaces (arrowheads). Axial bone tissue algorithm CT (C) shows osteolytic changes in the jaws, sclerotic 
lesions, sequestrum separation (arrow), and periosteal bone proliferation (arrowheads). On MRI, axial T1WI (D) revealed homogeneous, 
low-signal intensity with no hyperintensity, suggestive of sequestrum (arrow). Post-contrast T1WI (G) showed heterogeneous 
enhancement and a non-enhancing portion, suggestive of sequestrum (arrow). T2WI (E) and STIR (F) revealed heterogeneous, high-





MRI is able to demonstrate bone marrow changes asso-
ciated with edema or inflammation that result from an 
increase in water content, replacing the normal fatty 
marrow [2]. Regarding MRI of MRONJ, Bisdas et al. [9] 
indicated that the T1-weighted MRI signal was hypoin-
tense, the T2-weighted MRI signal was hypointense on the 
affected side, and pathological gadolinium enhancement 
was observed in the neighboring soft tissues, including the 
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masticator space. Krishnan et al. [1] showed that the ear-
liest MRI finding was the loss of the normal T1 hyperin-
tensity of fatty marrow in the mandible and maxilla, and 
the MRI findings of more advanced BRONJ included bone 
destruction, soft tissue edema and enhancement, inferior 
alveolar nerve thickening, and pterygoid muscle swelling 
and enhancement. In this study, we noted that MRONJ 
cases had intensity changes and pathological gadolinium 
enhancement on MRI.
99mTc HMDP uptake in the bone is dependent on osteoblas-
tic activity and skeletal vascularity [2]. Regarding bone 
scintigraphy of MRONJ, Krishnan et al. [1] indicated that 
bone scintigraphy showed increased uptake early in the 
disease. Hayama et al. [15] showed that dynamic analyses 
with a multicompartment model may help evaluate bone 
disorders in BRONJ. In this study, we show that MRONJ 
cases had increased uptake on bone scintigraphy.
This study had possible methodologic limitations. Potential 
selection bias cannot be excluded. Our sample was small, 
because relatively few patients have this rare disease.
Conclusions
In our study, the sequestrum separation on panoramic 
radiography in patients with MRONJ was unclear in com-
parison to CT. Furthermore, characteristic CT findings of 
MRONJ in patients in the parenteral group included peri-
osteal bone proliferation and spread of soft tissue inflam-
mation to buccal and other spaces. The results of the study 
present the multimodal imaging features of MRONJ. These 
findings can be helpful for diagnosis and management of 
MRONJ.
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